PROXY STATEMENT

Company

Oncotelic Therapeutics, Inc.

Filed

May 11, 2001

Period of Report

June 11, 2001

Accession Number

0000914121-01-500176

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →